Cargando…
T(H)9 cells in anti-tumor immunity
IL-9 was initially identified as a T cell growth factor with a potential oncogenic activity. Accordingly, IL-9 drives tumor growth in most hematological cancers. However, the links between IL-9 and cancer progression have been recently revisited following the discovery of T(H)9 cells. T(H)9 cells, w...
Autores principales: | Rivera Vargas, Thaiz, Humblin, Etienne, Végran, Frédérique, Ghiringhelli, François, Apetoh, Lionel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222918/ https://www.ncbi.nlm.nih.gov/pubmed/27832300 http://dx.doi.org/10.1007/s00281-016-0599-4 |
Ejemplares similares
-
Socs3 induction by PPARγ restrains cancer-promoting inflammation
por: Végran, Frédérique, et al.
Publicado: (2013) -
IRF8-dependent molecular complexes control the Th9 transcriptional program
por: Humblin, Etienne, et al.
Publicado: (2017) -
Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
por: Rivera Vargas, Thaiz, et al.
Publicado: (2019) -
Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells
por: Rivera Vargas, Thaiz, et al.
Publicado: (2017) -
Regulation of T cell antitumor immune response by tumor induced metabolic stress
por: Chalmin, Fanny, et al.
Publicado: (2018)